Showing results (31-40 of 67) with videos related to
Sort By:
Pageof 7
Deutsche Medizinische Wochenschrift (1946)|August 1, 1986
[The Munich follow-up program in advanced non-seminoma testicular tumors. Benefits and costs]C Clemm, W E Berdel, R Hartenstein, et al.Seminars in Oncology|April 1, 1997
Gemcitabine and etoposide in small cell lung cancer: phase I and II trialsI Rassmann, R Thödtmann, H Depenbrock, et al.Oncology|January 1, 1987
Benefit and costs of follow-up programs in nonseminomatous germ cell tumors of the stages IIb-IV: the Munich experienceW E Berdel, C Clemm, R Hartenstein, et al.Cancer Research|November 1, 1983
Cytotoxicity of thioether-lysophospholipids in leukemias and tumors of human originW E Berdel, M Fromm, U Fink, et al.Investigational New Drugs|January 1, 1995
Investigation of the comparative effects of 2-chlorodeoxyadenosine on tumor colony forming units in vitroH Depenbrock, M Wenger, R Peter, et al.Investigational New Drugs|January 1, 1996
Clinical and pharmacokinetic phase I trial of oral dimethylaminoetoposide (NK611) administered for 21 days every 35 daysI Rassmann, H Schrödel, T Schilling, et al.Journal of Lipid Mediators|September 1, 1990
Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitroS Danhauser-Riedl, A Himmelmann, G Steinhauser, et al.Investigational New Drugs|May 1, 1993
Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD)S Danhauser-Riedl, E Hausmann, H D Schick, et al.Immunobiology|December 1, 1982
Purification of human monocytes by adherence to polymeric fluorocarbon. Characterization of the monocyte-enriched cell fractionW E Berdel, U Fink, E Thiel, et al.Human Pathology|July 22, 1998
Molecular evidence of bone marrow involvement in advanced case ot Tgammadelta lymphoma with secondary myelofibrosisG Weirich, M Sandherr, C Fellbaum, et al.Pageof 7